德克斯梅德托米丁通过AMPK/PGC-1α通路促进线粒体生物发生,从而保持神经元功能
Li Wang1, Meng Zhang1, Shaowei Wang1
1The First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.
In vitro cellular & developmental biology. Animal
|July 7, 2025
概括
德克斯梅德托米丁 (Dex) 通过提高膜潜力,ATP生产和氧气消耗来增强线粒体功能. 这种效应是由AMP激活蛋白激酶 (AMPK) 激活的介导,这表明神经疾病的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 线粒体功能障碍与神经系统疾病的进展有关.
- 德克斯梅德托米丁 (Dex) 是一种α-2上腺激动剂,在线粒体功能中起着尚未研究的作用.
研究的目的:
- 为了研究德克斯梅德托米丁对线粒体功能和生物生成的影响.
- 为了阐明AMP激活蛋白激酶 (AMPK) 在Dexmedetomidine线粒体效应中的作用.
主要方法:
- 细胞被用不同度的Dexmedetomidine (Dex) 处理.
- 通过膜潜力,ATP生产和氧气消耗来评估线粒体功能.
- 基因和蛋白质表达分析通过qPCR和西部斑;AMPK抑制用于探测机制.
主要成果:
- 德克斯梅德托米丁显著改善了线粒体膜潜力,ATP生产和氧气消耗.
- 德克斯增加了关键线粒体基因 (mtND6,mtCO2,mtATP6) 和调节器 (Nrf1,TFAM,PGC-1α,p-AMPKα) 的表达.
- 抑制AMPK消除了Dex诱导的线粒体增强,证实了AMPK的重要作用.
结论:
- 德克斯梅德托米丁通过AMPK激活来增强线粒体功能和生物发生.
- 德克斯通过改善线粒体健康来证明其作为神经系统疾病治疗剂的潜力.
更多相关视频
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
247
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
247
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Adrenergic Agonists: Indirect-Acting Agents
1.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.9K
Sedatives and Hypnotics: Overview
670
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
670
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
213
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
213


